In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
QuidelOrtho Corporation (NASDAQ: QDEL) closed the day trading at $27.08 up 7.50% from the previous closing price of $25.19. In other words, the price has increased by $7.50 from its previous closing price. On the day, 1.56 million shares were traded. QDEL stock price reached its highest trading level at $27.125 during the session, while it also had its lowest trading level at $25.1125.
Ratios:
For a better understanding of QDEL, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.12 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 141.44. For the most recent quarter (mrq), Quick Ratio is recorded 0.62 and its Current Ratio is at 1.12. In the meantime, Its Debt-to-Equity ratio is 1.00 whereas as Long-Term Debt/Eq ratio is at 0.80.
On December 11, 2024, Citigroup Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $44 to $50.
On December 10, 2024, Jefferies started tracking the stock assigning a Hold rating and target price of $43.Jefferies initiated its Hold rating on December 10, 2024, with a $43 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 06 ’25 when The Bujarski 2007 Trust U/A Dt bought 100,200 shares for $47.50 per share.
Blaser Brian J. bought 6,033 shares of QDEL for $249,878 on Dec 11 ’24. The President and CEO now owns 6,033 shares after completing the transaction at $41.42 per share. On Dec 09 ’24, another insider, Robert Bujarski, who serves as the Former COO of the company, bought 20,000 shares for $40.40 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, QDEL now has a Market Capitalization of 1838745472 and an Enterprise Value of 4359612928. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.67 while its Price-to-Book (P/B) ratio in mrq is 0.66. Its current Enterprise Value per Revenue stands at 1.59 whereas that against EBITDA is 7.524.
Stock Price History:
The Beta on a monthly basis for QDEL is 0.13, which has changed by -0.39350504 over the last 52 weeks, in comparison to a change of 0.16657472 over the same period for the S&P500. Over the past 52 weeks, QDEL has reached a high of $49.45, while it has fallen to a 52-week low of $22.05. The 50-Day Moving Average of the stock is -2.21%, while the 200-Day Moving Average is calculated to be -22.85%.
Shares Statistics:
Over the past 3-months, QDEL traded about 1.47M shares per day on average, while over the past 10 days, QDEL traded about 1705920 shares per day. A total of 67.70M shares are outstanding, with a floating share count of 65.70M. Insiders hold about 3.24% of the company’s shares, while institutions hold 116.74% stake in the company. Shares short for QDEL as of 1753920000 were 6586431 with a Short Ratio of 4.47, compared to 1751241600 on 5868316. Therefore, it implies a Short% of Shares Outstanding of 6586431 and a Short% of Float of 16.11.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Currently, 7.0 analysts are dedicated to thoroughly evaluating and rating the performance of QuidelOrtho Corporation (QDEL) in the stock market.The consensus estimate for the next quarter is $0.97, with high estimates of $1.06 and low estimates of $0.76.
Analysts are recommending an EPS of between $2.45 and $2.27 for the fiscal current year, implying an average EPS of $2.34. EPS for the following year is $3.21, with 7.0 analysts recommending between $3.49 and $2.92.
Revenue Estimates
8 analysts predict $667.45M in revenue for the current quarter. It ranges from a high estimate of $701.6M to a low estimate of $655.2M. As of the current estimate, QuidelOrtho Corporation’s year-ago sales were $727.1MFor the next quarter, 8 analysts are estimating revenue of $733.69M. There is a high estimate of $760M for the next quarter, whereas the lowest estimate is $694.8M.
A total of 8 analysts have provided revenue estimates for QDEL’s current fiscal year. The highest revenue estimate was $2.72B, while the lowest revenue estimate was $2.69B, resulting in an average revenue estimate of $2.71B. In the same quarter a year ago, actual revenue was $2.78BBased on 8 analysts’ estimates, the company’s revenue will be $2.8B in the next fiscal year. The high estimate is $2.83B and the low estimate is $2.74B.
